Immuron Announces A$5.1M Private Placement to U.S. Fund

World News: . []

MELBOURNE Australia March 13 2018 GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) NASDAQIMRN an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatme...

More news and information about Immuron Limited

Published By:

Globe Newswire: 22:20 GMT Tuesday 13th March 2018

Published: .

Search for other references to "immuron" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us